Skip to content Skip to footer
Subscribe Now
INSIGHTS+

J.P. Morgan Healthcare Conference Special: Dealmaker of the Year 2025 (Part 02)  

Shots:  Novartis led biopharma dealmaking in 2025, executing 23 transactions worth $37.92B with a disciplined, high-impact strategy that balanced scale, science, and strategic fit    Dealmaking was spread across high-conviction areas; neuroscience, cardiovascular disease, immunology, and RNA platforms, combining transformational acquisitions with flexible licensing partnerships to build a future-ready pipeline    Standout transactions (Avidity, Monte…
January 16, 2026

Read more

EVENTS

Global Pharma Tech Summit 2026 | 18–19 May 2026 | Radisson Blu Hotel, London Heathrow

Global Pharma Tech Summit 2026 is a boutique, senior-level conference designed to bring together leaders from pharma, biotech, life sciences, and digital health to explore the practical application of technology across the healthcare value chain. The summit focuses on real-world use cases rather than sales-driven sessions, covering key areas such as AI and digital transformation…
January 7, 2026

Read more

Announcements

PharmaShots Ranked Among the Top 10 in Feedspot’s “45 Best Indian Pharma Blogs & Websites 2025” 

PharmaShots is proud to announce that we have been ranked 6th among the “45 Best Indian Pharma Blogs and Websites in 2025” by Feedspot, a leading platform that curates the best online content across industries.  This recognition underscores our commitment to delivering concise, credible, and high-impact biopharma and healthcare insights to our global audience. Being featured alongside some of…
October 18, 2025

Read more

VIEWPOINTS

Breaking New Ground in Oncology: Leonard Mazur from Citius Pharmaceuticals in Conversation with PharmaShots 

Shots:   Citius Pharmaceuticals celebrates its first-ever FDA approval with Lymphir, a novel therapy for relapsed or refractory cutaneous T-cell lymphoma     In an exclusive conversation, Leonard Mazur, Co-Founder and CEO at Citius Pharmaceuticals, shares insights on Lymphir’s launch strategy and its potential impact on the oncology landscape    Leonard also highlights Mino-Lok, Citius’ innovative…
October 6, 2025

Read more

EVENTS

Post Conference Highlights: Peptides & Complex Generics Symposium 2025

Day 1 Breakdown The #PCG2025 Symposium commenced on an inspiring note, setting the stage for two days of insightful discussions, collaborations, and knowledge exchange. Opening Session Dr. Ratnesh Jain, Founder & Director, Mumbai Cluster, delivered the inaugural address, sharing his vision of bringing together pharma professionals, R&D experts, CXOs, and academicians to accelerate advancements in…
September 29, 2025

Read more